Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for obstructive sleep apnea
IRCT20151227025726N26Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of agomelatine in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2021; status: completed.
02
Drugs
agomelatine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on IRCT20151227025726N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N26.